Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- SEARCHIndependent statistical analysis of Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup: Complete Statistical AnalysisIndependent statistical analysis of Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup:…
- Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SECOND-LINEIndependent statistical analysis of A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen: primary endpoint results,…
- SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil – Fast Admin: Complete Statistical AnalysisIndependent statistical analysis of SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01262989).
- SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil – Fed Admin: Complete Statistical AnalysisIndependent statistical analysis of SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01330303).
- Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00587132).
- Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA): Complete Statistical AnalysisIndependent statistical analysis of Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SECUREIndependent statistical analysis of A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SED-TUDIndependent statistical analysis of The Effects of Sedatives on Tobacco Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03813121).
- Sedentary Behavior Interrupted Randomized Controlled Trial (P2): Complete Statistical AnalysisIndependent statistical analysis of Sedentary Behavior Interrupted Randomized Controlled Trial (P2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03473145).
- SEENIndependent statistical analysis of Sexual and Gender Minority Emerging Adults Eliciting Narratives: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05899218).
- SEERSIndependent statistical analysis of mobiCARE™ ECG Monitoring System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06896734).
- SEGUDIABIndependent statistical analysis of SEGUDIAB Study: Evaluation of Safety in the Diabetic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01087541).
- SELECTIndependent statistical analysis of Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SELECT-3Independent statistical analysis of Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence…
- SELECT-BEYONDIndependent statistical analysis of A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or…
- SELECT-EARLYIndependent statistical analysis of A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate: primary endpoint results, effect estimate…
- SELECT2Independent statistical analysis of SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Selecting Insulin Analogs for Closed-Loop Control Using Multiplex Pharmacokinetic Profiling: Complete Statistical AnalysisIndependent statistical analysis of Selecting Insulin Analogs for Closed-Loop Control Using Multiplex Pharmacokinetic Profiling: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01684943).
- Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction: Complete Statistical AnalysisIndependent statistical analysis of Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02525718).
- SELECTSUNRISEIndependent statistical analysis of A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and…
- Selegiline Patch for Treatment of Nicotine Dependence: Complete Statistical AnalysisIndependent statistical analysis of Selegiline Patch for Treatment of Nicotine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01330030).
- Selenium and Immune Function: Complete Statistical AnalysisIndependent statistical analysis of Selenium and Immune Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00279812).
- Self Assembling Peptide P11-4 in Patients With Early Occlusal Carious Lesions: Complete Statistical AnalysisIndependent statistical analysis of Self Assembling Peptide P11-4 in Patients With Early Occlusal Carious Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Self-efficacy-based Auditory Rehabilitation With Over-the-Counter Hearing Aids: Complete Statistical AnalysisIndependent statistical analysis of Self-efficacy-based Auditory Rehabilitation With Over-the-Counter Hearing Aids: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06560918).
- Self-Management of Chronic Depressive Symptoms in Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Self-Management of Chronic Depressive Symptoms in Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02953990).
- Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet: Complete Statistical AnalysisIndependent statistical analysis of Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Self-System Therapy for Older Adults With Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Self-System Therapy for Older Adults With Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04057196).
- Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Selinexor and Pembrolizumab for the Treatment of Cisplatin-Ineligible or Cisplatin-Refractory Locally Advanced or Metastatic Urothelial Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Selinexor and Pembrolizumab for the Treatment of Cisplatin-Ineligible or Cisplatin-Refractory Locally Advanced or Metastatic Urothelial Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas: Complete Statistical AnalysisIndependent statistical analysis of Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SELPHIndependent statistical analysis of Intervention to Improve Expression of End of Life Preferences for Homeless Persons: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma: Complete Statistical AnalysisIndependent statistical analysis of Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Semaglutide for Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of Semaglutide for Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05520775).
- SEMMAPIndependent statistical analysis of NCCL Direct Composite Restoration Performance With Self-Etch and Multimode Adhesives: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02698371).
- SENECAIndependent statistical analysis of Stem Cell Injection in Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02509156).
- SENIORIndependent statistical analysis of Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications: primary endpoint results, effect estimate…
- Senolytic Drugs Attenuate Osteoarthritis-Related Articular Cartilage Degeneration: A Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Senolytic Drugs Attenuate Osteoarthritis-Related Articular Cartilage Degeneration: A Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04210986).
- SENSE-HFIndependent statistical analysis of Sensitivity of the InSync Sentry OptiVol Feature for the Prediction of Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sensoril(Ashwaganhda)for Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Sensoril(Ashwaganhda)for Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00761761).
- Sensory Effects of Rapidly-Changing Magnetic Fields: Complete Statistical AnalysisIndependent statistical analysis of Sensory Effects of Rapidly-Changing Magnetic Fields: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01632800).
- SentimarkIndependent statistical analysis of Magnetic Seed Localisation of Breast Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02635737).
- Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.: Complete Statistical AnalysisIndependent statistical analysis of Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.: primary endpoint results, effect…
- Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sequential and Hybrid Therapies for H Pylori Infection: Complete Statistical AnalysisIndependent statistical analysis of Sequential and Hybrid Therapies for H Pylori Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01085786).
- Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00856180).
- SequoiaIndependent statistical analysis of Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SERAPHIN OLIndependent statistical analysis of Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size…
- SERENA-2Independent statistical analysis of A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative…